Prevention, control and reflections on the imported and emerging trypanosomiasis in China

doi:10.20199/j.issn.1672-2302.2026.01.001

Abstract

Abstract:

Trypanosomiasis is a rare neglected tropical disease. China is beyond the endemic region for human trypanosomiasis. Nevertheless, multiple cases of imported human trypanosomiasis and locally acquired animal-borne trypanosomiasis have been reported in China in recent years. With the spread of American trypanosomiasis worldwide and cross-species infection of animal trypanosomiasis, trypanosomiasis is gradually becoming a non-negligible public health concern. This article provides an overview of the major human trypanosomiasis and the diagnosis and treatment processes of cases of imported and emerging trypanosomiasis in China, as well as a review of recent efforts to combat trypanosomiasis in China, aiming to provide a reference for the prevention and control of trypanosomiasis.

Key words: Trypanosomiasis, Imported case, Local case, Diagnosis, Treatment, Prevention and control

CLC Number:

R531.9

HUANG Lirong, SHEN Yong, WU Di, LIU Qin. Prevention, control and reflections on the imported and emerging trypanosomiasis in China[J]. Journal of Tropical Diseases and Parasitology, 2026, 24(1): 1-6.

Figures/Tables 1

References 62

[1]	Barrett MP, Burchmore RJ, Stich A, et al. The trypanosomiases[J]. Lancet, 2003, 362(9394):1469-1480. pmid: 14602444
[2]	Giordani F, Morrison LJ, Rowan TG, et al. The animal trypanosomiases and their chemotherapy: a review[J]. Parasitology, 2016, 143(14):1862-1889. pmid: 27719692
[3]	Ungogo MA, de Koning HP. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies[J]. Int J Parasitol Drugs Drug Resist, 2024, 25:100533. doi: 10.1016/j.ijpddr.2024.100533 URL
[4]	Liu Q, Zhou XN. Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries[J]. Infect Dis Poverty, 2015, 4:60. doi: 10.1186/s40249-015-0092-7 pmid: 26715535
[5]	Büscher P, Cecchi G, Jamonneau V, et al. Human African trypanosomiasis[J]. Lancet, 2017, 390(10110):2397-2409. doi: S0140-6736(17)31510-6 pmid: 28673422
[6]	Wang XY, Ruan QL, Xu B, et al. Human African trypanosomiasis in emigrant returning to China from Gabon,2017[J]. Emerg Infect Dis, 2018, 24(2):400-404. doi: 10.3201/eid2402.171583 URL
[7]	周菊静, 苏国平, 胡建忠,等. 江苏省江阴市一起输入性非洲锥虫病的流行病学调查[J]. 医学动物防制, 2019, 35(2):201-202.
[8]	Liu Q, Chen XL, Chen MX, et al. Trypanosoma brucei rhodesiense infection in a Chinese traveler returning from the Serengeti National Park in Tanzania[J]. Infect Dis Poverty, 2018, 7(1):50. doi: 10.1186/s40249-018-0432-5
[9]	Xu NN, Zhang XA, Liu H, et al. Clinical and epidemiological investigation of human infection with zoonotic parasite Trypanosoma dionisii in China[J]. J Infect, 2024, 89(5):106290. doi: 10.1016/j.jinf.2024.106290 URL
[10]	de Sousa AS, Vermeij D, Ramos AN, et al. Chagas disease[J]. Lancet, 2024, 403(10422):203-218. doi: 10.1016/S0140-6736(23)01787-7 pmid: 38071985
[11]	Kumar R, Gupta S, Bhutia WD, et al. Atypical human trypanosomosis: Potentially emerging disease with lack of understanding[J]. Zoonoses Public Hlth, 2022, 69(4):259-276. doi: 10.1111/zph.v69.4 URL
[12]	Lejon V, Lindner AK, Franco JR. Human African trypanosomiasis[J]. Lancet, 2025, 405(10482):937-950. doi: 10.1016/S0140-6736(25)00107-2 pmid: 40089378
[13]	刘琴, 陈木新, 李元元,等. 非洲锥虫病的诊断和治疗[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(5):435-442.
[14]	Barrett MP, Priotto G, Franco JR, et al. Elimination of human African trypanosomiasis: The long last mile[J]. PLoS Negl Trop Dis, 2024, 18(5):e0012091. doi: 10.1371/journal.pntd.0012091 URL
[15]	Gao JM, Qian ZY, Hide G, et al. Human African trypanosomiasis: the current situation in endemic regions and the risks for non-endemic regions from imported cases[J]. Parasitology, 2020, 147(9):922-931. doi: 10.1017/S0031182020000645 URL
[16]	林耀莹, 张山鹰, 谢汉国,等. 一例输入性非洲锥虫病的实验室诊断[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(4):366-369.
[17]	Deeks ED. Fexinidazole: first global approval[J]. Drugs, 2019, 79(2):215-220. doi: 10.1007/s40265-019-1051-6 pmid: 30635838
[18]	Bernhard S, Kaiser M, Burri C, et al. Fexinidazole for human African trypanosomiasis, the fruit of a successful public-private partnership[J]. Diseases, 2022, 10(4):90. doi: 10.3390/diseases10040090 URL
[19]	Imran M, Khan SA, Alshammari MK, et al. Discovery, development,inventions and patent review of fexinidazole: the first all-oral therapy for human African trypanosomiasis[J]. Pharmaceuticals, 2022, 15(2):128. doi: 10.3390/ph15020128 URL
[20]	Lindner AK, Lejon V, Barrett MP, et al. New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine[J]. Lancet Infect Dis, 2025, 25(2):e77-e85. doi: 10.1016/S1473-3099(24)00581-4 URL
[21]	Tarral A, Hovsepian L, Duvauchelle T, et al. Determination of the optimal single dose treatment for acoziborole, a novel drug for the treatment of human African trypanosomiasis: first-in-human study[J]. Clin Pharmacokinet, 2023, 62(3):481-491. doi: 10.1007/s40262-023-01216-8 pmid: 36763327
[22]	Dickie EA, Giordani F, Gould MK, et al. New drugs for human African trypanosomiasis: a twenty first century success story[J]. Trop Med Infect Dis, 2020, 5(1):29.
[23]	Gillon JY, Simon F, Sidhu S, et al. Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans[J]. Antimicrob Agents Chemother, 2025, 69(11):e00580-25.
[24]	Swett MC, Rayes DL, Campos SV, et al. Chagas disease: epidemiology, diagnosis, and treatment[J]. Curr Cardiol Rep, 2024, 26(10):1105-1112. doi: 10.1007/s11886-024-02113-7 pmid: 39115799
[25]	Castillo-Riquelme M. Chagas disease in non-endemic countries[J]. Lancet Glob Health, 2017, 5(4):e379-e380. doi: 10.1016/S2214-109X(17)30090-6 pmid: 28256341
[26]	Beatty NL, Hamer GL, Moreno-Peniche B, et al. Chagas disease, an endemic disease in the United States[J]. Emerg Infect Dis, 2025, 31(9):1691-1697. doi: 10.3201/eid3109.241700 pmid: 40866797
[27]	Hotez PJ, Dumonteil E, Woc-Colburn L, et al. Chagas disease: “the new HIV/AIDS of the americas”[J]. PLoS Negl Trop Dis, 2012, 6(5):e1498. doi: 10.1371/journal.pntd.0001498 URL
[28]	Echavarría NG, Echeverría LE, Stewart M, et al. Chagas disease: chronic chagas cardiomyopathy[J]. Curr Probl Cardiol, 2021, 46(3):100507. doi: 10.1016/j.cpcardiol.2019.100507 URL
[29]	王梦霞, 刘琴. 细胞遗传学用于锥猎蝽亚科物种分类的研究进展[J]. 中国媒介生物学及控制杂志, 2021, 32(1):115-119. doi: 10.11853/j.issn.1003.8280.2021.01.025
[30]	Salazar R, Castillo-Neyra R, Tustin AW, et al. Bed bugs (Cimex lectularius) as vectors of Trypanosoma cruzi[J]. Am J Trop Med Hyg, 2015, 92(2):331-335. doi: 10.4269/ajtmh.14-0483 URL
[31]	Freire ES, da Silva LP, do Carmo Silva A, et al. New drugs and promising drug combinations in the treatment of chagas disease in Brazil: a systematic review and meta-analysis[J]. Arch Med Res, 2025, 56(1):103084. doi: 10.1016/j.arcmed.2024.103084 URL
[32]	Malone CJ, Nevis I, Fernández E, et al. A rapid review on the efficacy and safety of pharmacological treatments for Chagas disease[J]. Trop Med Infect Dis, 2021, 6(3):128.
[33]	Khare S, Liu XZ, Stinson M, et al. Antitrypanosomal treatment with benznidazole is superior to posaconazole regimens in mouse models of Chagas disease[J]. Antimicrob Agents Chemother, 2015, 59(10):6385-6394. doi: 10.1128/AAC.00689-15 pmid: 26239982
[34]	Rao SPS, Gould MK, Noeske J, et al. Cyanotriazoles are selective topoisomerase Ⅱpoisons that rapidly cure trypanosome infections[J]. Science, 2023, 380(6652):1349-1356. doi: 10.1126/science.adh0614 URL
[35]	Okello I, Mafie E, Eastwood G, et al. African animal trypanosomiasis: a systematic review on prevalence,risk factors and drug resistance in sub-Saharan Africa[J]. J Med Entomol, 2022, 59(4):1099-1143. doi: 10.1093/jme/tjac018 pmid: 35579072
[36]	祖力亚·克力木江, 努尔·库尔玛那里, 阿不来, 等. 伊犁河谷地域虻的鉴定及其携带伊氏锥虫的检测[J]. 动物医学进展, 2021, 42(9):141-144.
[37]	孙小康, 黄金英, 邓远玲,等. 广东清远地区路氏锥虫人群和宿主动物感染调查[J]. 华南预防医学, 2013, 39(1):76-78.
[38]	Jain P, Goyal V, Agrawal R. An atypical Trypanosoma lewisi infection in a 22-day-old neonate from India: an emergent zoonosis[J]. Indian J Pathol Microbiol, 2023, 66(1):199-201. doi: 10.4103/ijpm.ijpm_449_22 URL
[39]	Lun ZR, Reid SA, Lai DH, et al. Atypical human trypanosomiasis: a neglected disease or just an unlucky accident?[J]. Trends Parasitol, 2009, 25(3):107-108. doi: 10.1016/j.pt.2008.12.001 URL
[40]	Malysheva MN, Ganyukova AI, Frolov AO, et al. The mite Steatonyssus periblepharus is a novel potential vector of the bat parasite Trypanosoma dionisii[J]. Microorganisms, 2023, 11(12):2906. doi: 10.3390/microorganisms11122906 URL
[41]	Moloo SK, Kabata JM, Gitire NM. Study on the mechanical transmission by tsetse fly Glossina morsitans centralis of Trypanosoma vivax, T. congolense or T. brucei brucei to goats[J]. Acta Trop, 2000, 74(1):105-108. pmid: 10643915
[42]	孙懿, 黄韦华, 牛紫光,等. 1例输入性非洲锥虫病的病原学鉴定[J]. 中国寄生虫学与寄生虫病杂志, 2016, 34(4):350-354.
[43]	张婷婷. 1例输入性非洲锥虫病病人的护理[J]. 护理研究, 2015, 29(31):3965-3967.
[44]	徐晶晶, 陈念, 金柯,等. 依氟鸟氨酸治疗1例非洲锥虫病的不良反应分析[J]. 药学与临床研究, 2015, 23(4):417-418.
[45]	Chen N, Jin K, Xu JJ, et al. Human African trypanosomiasis caused by Trypanosoma brucei gambiense: The first case report in China[J]. Int J Infect Dis, 2019, 79:34-36.
[46]	李元元, 陈小玲, 刘青,等. 2例输入性非洲锥虫病的随访预后研究[J]. 中国血吸虫病防治杂志, 2021, 33(3):293-296.
[47]	刘青, 陈小玲, 郑华,等. 国内首例输入性罗得西亚锥虫病诊疗启示[J]. 中华卫生应急电子杂志, 2018, 4(6):381-383.
[48]	中国疾病预防控制中心. 关于印发输入性非洲锥虫病防控方案(试行版)和输入性美洲锥虫病防控方案(试行版)的通知:中疾控传防发〔2015〕20号[A/OL]. (2015-01-29)[2025-11-18]. https://www.tdrc.org.cn/html/1/309/1585.html.
[49]	Liu Q, Wu FW, Shi YL, et al. Distribution of triatomines,the vector of Chagas disease - Southern China, 2016-2018[J]. China CDC Wkly, 2020, 2(33):629-633.
[50]	Shi YL, Wei YB, Feng XY, et al. Distribution, genetic characteristics and public health implications of Triatoma rubrofasciata, the vector of Chagas disease in Guangxi, China[J]. Parasit Vectors, 2020, 13(1):33. doi: 10.1186/s13071-020-3903-z
[51]	徐建敏, 陈守义, 魏跃红,等. 广州市锥蝽侵害及叮咬状况调查与分析[J]. 中华卫生杀虫药械, 2020, 26(5):439-441.
[52]	Guo YH, Shi YL, Zhang Y, et al. Modelling the ecological suitability of the Chagas disease vector Triatoma rubrofasciata- China[J]. China CDC Wkly, 2021, 3(35):736-740.
[53]	王子怡, 田芸嘉, 徐焕志,等. 海南省两地红带锥蝽体内锥虫的感染情况和分子特征[J]. 中国动物传染病学报, 2024, 32(5):171-178.
[54]	Dong L, Ma XL, Wang MF, et al. Complete mitochondrial genome of the Chagas disease vector, Triatoma rubrofasciata[J]. Korean J Parasitol, 2018, 56(5):515-519. doi: 10.3347/kjp.2018.56.5.515 pmid: 30419739
[55]	Liu Q, Guo YH, Zhang Y, et al. A chromosomal-level genome assembly for the insect vector for Chagas disease, Triatoma rubrofasciata[J]. Gigascience, 2019, 8(8):giz089.
[56]	Duan L, Tian YJ, Wang ZY, et al. Transcriptomic comparison analysis across seven developmental stages of the Triatoma rubrofasciata, a vector of Chagas disease[J]. BMC Genomics, 2025, 26(1):444. doi: 10.1186/s12864-025-11632-8 pmid: 40325364
[57]	Liu Q, Chen MX, Cai YC, et al. Trypanosoma dionisii in China: ecology and tentative epidemiology[J]. Infect Dis Poverty, 2025, 14(1):61. doi: 10.1186/s40249-025-01336-2
[58]	杨富升, 古小彬. 近十年PCR技术在寄生虫病诊断中的应用[J]. 畜牧兽医学报, 2023, 54(8):3183-3194. doi: 10.11843/j.issn.0366-6964.2023.08.006
[59]	王渊, 刘永杰, 金子懿,等. 两种锥虫双重实时荧光PCR检测方法的建立[J]. 中国口岸科学技术, 2022, 4(2):4-8.
[60]	姚璎, 杲光伟, 李大伟. 布氏锥虫亮氨酰-tRNA合成酶的克隆表达纯化及活性测定[J]. 中国生化药物杂志, 2010, 31(1):14-18.
[61]	Zhao YX, Wang Q, Meng QQ, et al. Identification of Trypanosoma brucei leucyl-tRNA synthetase inhibitors by pharmacophore- and docking-based virtual screening and synthesis[J]. Bioorg Med Chem, 2012, 20(3):1240-1250. doi: 10.1016/j.bmc.2011.12.035 URL
[62]	刘焕香, 李沁, 唐海谊, 等. 一种用于治疗锥虫病的药物:CN119909070A[P]. 2025-05-02.

锥虫虫种	可能的传播媒介	参考治疗药物
狄氏锥虫（T. doinisii)	蝙蝠臭虫、革螨	苯硝唑
路氏锥虫（T. lewisi）	鼠蚤	苏拉明、庆大霉素、两性霉素B、头孢曲松、喷他脒、阿米卡星、美拉胂醇和泼尼松龙
伊氏锥虫（T. evansi）	虻类、马蝇	苏拉明、双氢青蒿素-哌喹、两性霉素B
布氏锥虫布氏亚种（T. b. brucei）	采采蝇	苏拉明
刚果锥虫（T. congolense）	采采蝇	喷他脒
活泼锥虫（T. vivax）	采采蝇	二脒那秦乙酰甘氨酸盐、氯化异甲咪胺、菲啶类药物